During the past decade, Oncology Hematology Associates conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Associates" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Hematology Associates" are "Stage IIIA Lung Cancer AJCC v8" (2 trials), "Stage IIIB Lung Cancer AJCC v8" (2 trials), "ALK Gene Rearrangement" (1 trials), "ALK Gene Translocation" (1 trials) and "ALK Positive" (1 trials). Many other conditions were trialed in "Oncology Hematology Associates" in a lesser frequency.

Most popular intervention types in "Oncology Hematology Associates" are "Drug" (12 trials), "Other" (7 trials), "Biological" (6 trials), "Procedure" (6 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (5 trials), "Magnetic Resonance Imaging" (4 trials), "Quality-of-Life Assessment" (4 trials), "Atezolizumab" (3 trials) and "Biospecimen Collection" (3 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Hematology Associates" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Oncology Hematology Associates". undefined are not yet recruiting, 9 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oncology Hematology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Hematology Associates, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".